Quinn Timothy D, Brovman Ethan Y, Urman Richard D
1 Department of Anesthesiology, Critical Care and Pain Medicine, Roswell Park Cancer Institute , Buffalo, New York.
2 Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo , Buffalo, New York.
J Laparoendosc Adv Surg Tech A. 2017 Sep;27(9):892-897. doi: 10.1089/lap.2017.0336. Epub 2017 Jul 25.
Fluid therapy in the perioperative period varies greatly between anesthesia providers and may have a negative impact on surgical outcomes.
We conducted a retrospective analysis of 705 elective colorectal cases consisting of colectomies, ileocolic resections, and low anterior resections at an academic institution from January 1, 2010 to May 29, 2015, collected by our electronic medical record before implementation of Enhanced Recovery After Surgery (ERAS) pathways.
The mean for total crystalloid administration was 2578 mL with a standard deviation (SD) that was approximately 50% of the mean value. A combination of both normal saline and lactated Ringer's solution was used in almost all cases without a clear rationale for fluid choice. Fluid administered to patients was disproportional to measured intraoperative fluid losses (estimated blood loss and urine output) by a factor of 10. The average rate of fluid given was 1050 mL/h with an SD of nearly the same amount (951 mL). There was a variability of over 67% in total crystalloid administered based on both ideal body weight and total body weight.
We found that a wide variability in the amount and type of fluid therapy administered existed at our institution before implementation of a colorectal ERAS pathway or routine use of goal-directed fluid therapy (GDFT). ERAS pathways with GDFT protocols could lead to more rational and consistent fluid therapy leading to improved outcomes.
围手术期的液体治疗在麻醉医生之间差异很大,可能会对手术结果产生负面影响。
我们对2010年1月1日至2015年5月29日在一所学术机构进行的705例择期结直肠手术病例进行了回顾性分析,这些病例包括结肠切除术、回结肠切除术和低位前切除术,数据由我们的电子病历收集,当时尚未实施加速康复外科(ERAS)路径。
晶体液总输注量的平均值为2578毫升,标准差(SD)约为平均值的50%。几乎所有病例均同时使用了生理盐水和乳酸林格氏液,选择液体时并无明确的依据。给予患者的液体量与术中测量的液体丢失量(估计失血量和尿量)不成比例,相差达10倍。液体输注的平均速率为1050毫升/小时,标准差与该数值相近(为951毫升)。基于理想体重和总体重,晶体液总输注量的变异性超过67%。
我们发现,在实施结直肠ERAS路径或常规使用目标导向液体治疗(GDFT)之前,我们机构在液体治疗的量和类型方面存在很大差异。采用GDFT方案的ERAS路径可能会带来更合理、一致的液体治疗,从而改善治疗结果。